Saluda’s long journey towards hitting the ASX pain barrier
Saluda had a disastrous debut on the ASX on Friday, shedding half its value. But here’s the inside story of resilience in the company that learnt how to read signals going up the spinal cord and to turned them into pain relief. Saluda founder John Parker has just delivered a talk at an international biomedical […]